An investigation of the long-term benefits of antidepressant medication in the recovery of patients with chronic fatigue syndrome

Human Psychopharmacology

Volumn 21, Issue 8, 2006, Pages 503-509

  Thomas, Marie A ^a   Smith, Andrew P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antidepressant medication; Chronic fatigue syndrome; Recovery

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANAMNESIS; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; SLEEP;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; DEPRESSIVE DISORDER; FATIGUE SYNDROME, CHRONIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SLEEP;

EID: 33846084724     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.805     Document Type: Article

References (17)

1. Andersen MM, Permin IH, Albrecht F. 2004. Illness and disability in Danish chronic fatigue syndrome patients at diagnosis and 5-year follow up. J Psychosom Res 56: 217-229.
2. Antelman SM, Gershon S. 1998. Clinical application of time-dependant sensitization to antidepressant therapy. Prog Neuropsychopharmacol Biol Psychiatry 22: 65-78.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbough J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
4. Fukuda K, Straus S, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, International Chronic Fatigue Syndrome Study Group. 1994. The Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121: 953-959.
5. Goodnick PJ, Sandoval R, Brickman A, Klimas NG. 1992. Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. Biol Psychiatry 32: 834-838.
6. Hickie I. 1999. Nefazodone for patients with chronic fatigue syndrome. Aust NZ J Psychiatry 33: 278-280.
7. Holmes GP, Kaplan JE, Gantz NM, et al. 1988. CFS: a working case definition. Ann Intern Med 108: 387-389.
8. Natelson BH, Cheu J, Pareja J, Ellis SP, Policastro T, Findley TW. 1996. Randomised, double-blind, controlled placebo-phase in trial of low-dose phenelzine in the chronic fatigue syndrome. Psychopharmacology 124: 226-230.
9. O'Malley PG, Jackson JL, Santoro J, et al. 1999. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 48: 980-990.
10. Ray C, Weir WRC, Stewart D, Millar P, Hyde G. 1993. Ways of coping with CFS: development of an illness management questionnaire. Soc Sci Med 37: 385-391.
11. Rimes KA, Chalder T. 2005. Treatments for chronic fatigue syndrome. Occup. Med. 55: 32-39.
12. Sharpe M, Archard L, Banatvala J, et al. 1991. CFS: guidelines for research. J R Soc Med 84: 118-121.
13. Smith A, Pollock J, Thomas M, Llewelyn M, Borysiewicz L. 1996. The relationship between subjective ratings of sleep and mental functioning in healthy subjects and patients with chronic fatigue syndrome. Hum Psychopharmocol 11: 161-167.
14. Spielberger C, Gorsuch R, Lushene RE. 1971. STAI Manual for the Stait-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto.
15. Surawy C, Hackman A, Hawton K, Sharpe M. 1995. CFS: a cognitive approach. Behav Res Ther 33: 535-544.
16. Vercoulen J, Swanink CM, Zitman FG, et al. 1996. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347: 1292-1298.
17. Wearden AJ, Morriss RK, Mullis R, et al. 1998. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 172: 485-490.